http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053081-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a4c6dfffdb8ee797f6ec1d9a1005ed3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4468fc75dcfd46910b4cd8618fcac652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8979f668f006ff308baf5a67e4889779 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3cc5f1d37839ce5fba449eb0895c20b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2003-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cadd92f456be2d41541e90e6ac34e5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e34789262fd82bd78669fdf1492bd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c126e6d7304945215d23472a8acb07da |
| publicationDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004053081-A2 |
| titleOfInvention | Compositions, splice variants and methods relating to prostate specific genes and proteins |
| abstract | The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053081-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053081-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2333112-A2 |
| priorityDate | 2002-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3242.